Uncovering heart failure in patients with a history of pulmonary disease: Rationale for the early use of B-type natriuretic peptide in the emergency department

Academic Emergency Medicine

Volumn 10, Issue 3, 2003, Pages 198-204

  McCullough, Peter A ^a   Hollander, Judd E ^b   Nowak, Richard M ^c   Storrow, Alan B ^d   Duc, Philippe ^e   Omland, Torbjørn ^f   McCord, James ^c   Herrmann, Howard C ^b   Steg, Philippe G ^e   Westheim, Arne ^f   Knudsen, Cathrine Wold ^f   Abraham, William T ^g   Lamba, Sumant ^g   Wu, Alan H B ^h   Perez, Alberto ^h   Clopton, Paul ⁱ   Krishnaswamy, Padma ⁱ   Kazanegra, Radmila ⁱ   Maisel, Alan S ⁱ  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e BICHAT HOSPITAL   (France)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF KENTUCKY   (United States)

^h HARTFORD HOSPITAL   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asthma; Bronchospasm; Chronic obstructive lung disease; Diagnosis; Heart failure; Natriuretic peptides

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DYSPNEA; ELECTROCARDIOGRAM; EMERGENCY TREATMENT; FEMALE; GENDER; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; HYPERTENSION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RACE; STABLE ANGINA PECTORIS; STATISTICAL ANALYSIS; THORAX RADIOGRAPHY; WHEEZING;

EID: 0037336072     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/aemj.10.3.198     Document Type: Article

References (30)

1. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (R.E.A.C.H.) study. J Am Coll Cardiol. 2002;39:60-9.
2. Graves EJ. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1990. Washington, DC: U.S. Department of Health and Human Services, National Center for Health Statistics, Vital and Health Statistics, 1991. (Series 13, No 113, DHHS Publ No (PHS) 92-1774).
3. Hoes AW, Mosterd A, Grobbee DE. An epidemic of heart failure? Recent evidence from Europe. Eur Heart J. 1998; 19(suppl L):L2-9.
4. Weiss ST. Epidemiology and heterogeneity of asthma. Ann Allergy Asthma Immunol. 2001 Jul; 87(1 suppl 1):5-8.
5. Guidotti TL, Jhangri GS. Mortality from airways disorders in Alberta, 1927-1987: an expanding epidemic of COPD, but asthma shows little change. J Asthma. 1994; 31:277-90.
6. Coughlin SS, Szklo M, Baughman K, Pearson TA. Idiopathic dilated cardiomyopathy and atopic disease: epidemiologic evidence for an association with asthma. Am Heart J. 1989; 118:768-74.
7. Sengstock D, Pasnoori V, Obaidat O, Mehra P, Marks KR, McCullough PA. Asthma, beta-agonists, and the development of congestive heart failure: results of the A.B.C.H.F. study. J Card Failure. 2002; 8:232-8.
8. Nagagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I. Rapid transcriptional activation and early m RNA turnover of BNP in cardiocyte hypertrophy. Evidence for BNP as an "emergency" cardiac hormone against ventricular overload. J Clin Invest. 1995; 96:1280-7.
9. Maeda K, Takayoshi T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998; 135:825-32.
10. Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med. 2002; 39:131-8.
11. Maisel AS, Krishnaswamy P, Nowak RM, et al., for the BNP Multinational Study Investigators. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure: primary results from the Breathing Not Properly (BNP) Multinational Study. N Engl J Med. 2002; 347:161-7.
12. McCullough PA, Nowak RM, McCord J, et al., for the BNP Multinational Study Investigators. B-type natriuretic peptide and clinical judgment in the emergency diagnosis of heart failure: an analysis from the Breathing Not Properly (BNP) Multinational Study. Circulation. 2002; 106:416-22.
13. Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001; 37:386-91.
14. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002; 39:202-9.
15. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med. 1971; 285:1441-6.
16. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992; 20:301-6.
17. Philbin EF. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting. Clin Cardiol. 1998; 21:103-8.
18. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997; 96:509-16.
19. Luchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol. 1998; 274(5 pt 2): H1684-9.
20. Sudoh T, Maekawa K, Kojima M, Minamino N, Kangawa K, Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun. 1989; 159:1427-34.
21. Kojima M, Minamino N, Kangawa K, Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. Biochem Biophys Res Commun. 1989; 159:1420-6.
22. Pedersen EB, Pedersen HB, Jensen KT. Pulsatile secretion of atrial natriuretic peptide and brain natriuretic peptide in healthy humans. Clin Sci (Lond). 1999; 97:201-6.
23. Parmley WW. Pathophysiology of congestive heart failure. Am J Cardiol. 1985; 56(2):7A-11A.
24. Wegner M, Ganten D, Stasch JP. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats. Hypertens Res. 1996; 19:229-38.
25. Ozaki J, Shimizu H, Hashimoto Y, Itoh H, Nakao K, Inui K. Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides. Eur J Pharmacol. 1999; 370:307-12.
26. Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol. 1995; 44(suppl 1):S61-4.
27. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001; 345:1014-21.
28. McCullough PA, Philbin EF, Spertus JA, Sandberg KR, Sullivan RA, Kaatz S. Opportunities for improvement in the diagnosis and treatment of heart failure. Clin Cardiol. 2003; in press.
29. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995; 333:1190-5.
30. Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet. 1999; 354:1077-83.